Triptolide lactone ring derivatives as immunomodulators and anticancer agents

Details for Australian Patent Application No. 2005218610 (hide)

Owner Pharmagenesis, Inc.

Inventors Yuan, Hongwei; Dai, Dongcheng; Musser, John H.

Agent FB Rice

Pub. Number AU-B-2005218610

PCT Pub. Number WO2005/084365

Priority 60/549,769 02.03.04 US

Filing date 2 March 2005

Wipo publication date 15 September 2005

Acceptance publication date 18 August 2011

International Classifications

C07D 307/77 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/365 (2006.01) - Lactones

C07D 307/93 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/084365 Priority application(s): WO2005/084365

18 August 2011 Application Accepted

  Published as AU-B-2005218610

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005218611-Transcription factor RNA interference reagents and methods of use thereof

2005218606-Multi-component biological transport systems